Spectrum and Outcome of Prenatally Diagnosed Fetal Primary Cardiomyopathies—A Twenty-Year Overview

Objective: to assess the course and outcome of fetuses affected by primary cardiomyopathy (CM). Methods: Retrospective study of 21 cases with prenatal diagnosis of a primary CM in one tertiary center over a period of 20 years. Charts were reviewed for echocardiographic findings, pregnancy outcome, and postnatal course. The utility of prenatal evaluation was discussed. Results: The mean gestational age (GA) at diagnosis was 26.7 (±5.1) weeks. A total of 33.3% (7/21) had associated anomalies. Genetic etiology was confirmed in 50.0% (10/20, with one case lost to follow up). The overall survival rate of the entire study population was 40% (8/20) including termination of pregnancy in 20% (4/20) and an intrauterine mortality rate of 5% (1/20). Of the initial survivors (n = 15), a neonatal and early infant mortality rate of 46.7% (7/15) was calculated. Prenatal isolated right ventricular involvement was the only identified significant parameter for survival (p = 0.035). Four phenotypical groups were identified: 42.9% (9/21) hypertrophic (HCM), 38.1% (8/21) dilated (DCM), 14.3% (3/21) isolated noncompaction (NCCM), and 4.8% (1/21) restrictive CM (RCM). Fetuses assigned to isolated NCCM revealed a 100% survival rate. Conclusion: Prenatal detection is feasible but needs to a introduce classification method for better consulting and management practices. A poor outcome is still observed in many cases, but an increase in examiners’ awareness may influence optimal multispecialized care.

[1]  R. Weintraub,et al.  Overview of Cardiomyopathies in Childhood , 2021, Frontiers in Pediatrics.

[2]  A. Baschat,et al.  ISUOG Practice Guidelines (updated): use of Doppler velocimetry in obstetrics , 2021, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[3]  L. Hornberger,et al.  Clinical presentation, genetic etiology and outcome associated with fetal cardiomyopathy: comparison of two eras , 2021, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[4]  Jiancheng Han,et al.  Genetics and Clinical Features of Noncompaction Cardiomyopathy in the Fetal Population , 2021, Frontiers in Cardiovascular Medicine.

[5]  E. Gratacós,et al.  Reference ranges for fetal cardiac, ventricular and atrial relative size, sphericity, ventricular dominance, wall asymmetry and relative wall thickness from 18 to 41 gestational weeks , 2020, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[6]  J. Parent,et al.  Fetal Echocardiography is Useful for Screening Fetuses with a Family History of Cardiomyopathy , 2019, Pediatric Cardiology.

[7]  D. Judge,et al.  Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG) , 2018, Genetics in Medicine.

[8]  M. Ackerman,et al.  Idiopathic Restrictive Cardiomyopathy in Children and Young Adults. , 2018, The American journal of cardiology.

[9]  S. Deshpande,et al.  Genetic Testing in Pediatric Cardiomyopathy , 2018, Pediatric Cardiology.

[10]  M. Zugaib,et al.  A Prenatal Case of Arrhythmogenic Right Ventricular Dysplasia , 2018, Arquivos brasileiros de cardiologia.

[11]  S. Colan,et al.  Survival Without Cardiac Transplantation Among Children With Dilated Cardiomyopathy. , 2017, Journal of the American College of Cardiology.

[12]  B. Maron,et al.  Classification, Epidemiology, and Global Burden of Cardiomyopathies. , 2017, Circulation research.

[13]  U. Bauer,et al.  Changing Prevalence of Severe Congenital Heart Disease: Results from the National Register for Congenital Heart Defects in Germany , 2017, The Thoracic and Cardiovascular Surgeon.

[14]  S. Maskatia,et al.  Echocardiographic Parameters and Outcomes in Primary Fetal Cardiomyopathy , 2016, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[15]  F. Dallaire,et al.  Reference Values and Z Scores for Pulsed-Wave Doppler and M-Mode Measurements in Fetal Echocardiography. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[16]  S. Ohno,et al.  Fetal arrhythmogenic right ventricular cardiomyopathy with double mutations in TMEM43 , 2016, Pediatrics international : official journal of the Japan Pediatric Society.

[17]  S. Colan,et al.  Cardiomyopathy Phenotypes and Outcomes for Children With Left Ventricular Myocardial Noncompaction: Results From the Pediatric Cardiomyopathy Registry. , 2015, Journal of cardiac failure.

[18]  J. Finsterer,et al.  Fetal Ventricular Hypertrabeculation/Noncompaction: Clinical Presentation, Genetics, Associated Cardiac and Extracardiac Abnormalities and Outcome , 2015, Pediatric Cardiology.

[19]  D. Chitayat,et al.  Spectrum and outcome of primary cardiomyopathies diagnosed during fetal life. , 2014, JACC. Heart failure.

[20]  B. Tutschek,et al.  ISUOG Practice Guidelines (updated): sonographic screening examination of the fetal heart , 2013, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[21]  J. Rychik,et al.  Diagnosis and management of heart failure in the fetus. , 2012, Minerva pediatrica.

[22]  E. Gratacós,et al.  Fetal Cardiac Function: Technical Considerations and Potential Research and Clinical Applications , 2012, Fetal Diagnosis and Therapy.

[23]  G. Fazio,et al.  Diagnosis and prognosis of fetal cardiomyopathies: a review. , 2010, Current pharmaceutical design.

[24]  E. Trulock,et al.  Registry of the International Society for Heart and Lung Transplantation: tenth official pediatric lung and heart/lung transplantation report--2007. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[25]  Barry J Maron,et al.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.

[26]  J M Simpson,et al.  Repeatability of echocardiographic measurements in the human fetus , 2002, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[27]  R. Weintraub,et al.  Outcome of idiopathic restrictive cardiomyopathy in children. , 2002, The American journal of cardiology.

[28]  J. Smallhorn,et al.  Fetal Cardiomyopathies: Pathogenic Mechanisms, Hemodynamic Findings, and Clinical Outcome , 2002, Circulation.

[29]  P. Kaufmann,et al.  Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy , 2001, Heart.

[30]  G. Fontaine,et al.  Prenatal Echocardiographic Appearance of Arrhythmogenic Right Ventricle Dysplasia: A Case Report , 2001, Fetal Diagnosis and Therapy.

[31]  R. Chaoui,et al.  Fetal cardiomegaly: echocardiographic findings and outcome in 19 cases. , 1994, Fetal diagnosis and therapy.

[32]  N. Silverman,et al.  Cardiac dimensions determined by cross-sectional echocardiography in the normal human fetus from 18 weeks to term. , 1992, The American journal of cardiology.

[33]  N. Silverman,et al.  Echocardiographic evaluation of dilated cardiomyopathy in the human fetus. , 1989, The American journal of cardiology.